SLC16A1 and breast carcinoma: As reported by Guan, AR-C155858 may be an MCT1 substrate, and ARC155858 and AZD3965 both exhibit gradual reversible suppression of MCT1-mediated L-lactate uptake in breast cancer cells [10].